Detection Time of Drugs of Abuse in Urine

References

• Procedures for transportation workplace drug and alcohol testing programs; Proposed rules. Federal Register, December 9 1999: 64, No 2.
   Google Scholar
• De la Torre R, Segura J, de Zeeuw R, Williams J. Recommendations for the reliable detection of illicit drugs in urine in the Eu-ropean Union, with special attention to the workplace. Ann Clin Biochem 1997; 34: 339–44.
   Google Scholar
• Braithwaite RA, Jarvie DR, Minty PSB, Simpson D, Widdop B. Screening for drugs of abuse : I Opiates, amphetamines and co-caine. Ann Clin Biochem. 1995; 32: 123–53.
   Google Scholar
• Ghysel M. Amphétamines et dérivés. In : Kintz P. Toxicologie et pharmacologie médicolégales. Paris : Elsevier. 1998: 465–541.
   Google Scholar
• Osterloh JD. Amphetamines. In : Caplan YH, Ed. Abused drugs monograph series. Abbott Laboratories, Diagnostics Division, Irving Tx, 1994.
   Google Scholar
• Baselt RC. Amphetamine. In : Baselt RC. Disposition of toxic drugs and chemicals in man. Foster City, California : Chemical Toxicology Institute. 2000: 49–51.
   Google Scholar
• Samyn N, Viaene B, Vandevenne L, Verstraete A. Deliverable D2 : Inventory of state-of-the-art road side drug testing equipment. D2, Rosita consortium, Gent, 1999. p. 1–86.
   Google Scholar
• Ensslin HK, Kovar KA, Maurer HH. Toxicological detection of designer drug 3,4-methylenedioxyethylamphetamine and its metabolites in urine by GC-MS and FPIA. J. Chromatogr B Biomed Appl 1996; 683: 189–97
   Google Scholar
• Verstraete A, Van haute I. Spécificité des immunoessais pour la détection des amphétamines. Toxicorama 1997; 9: 65 - 71.
   Google Scholar
• Smith-Kielland A, Skuterud B, Mϕrland J. Urinary excretion of amphetamine after termination of drug abuse. J Anal Toxicol 1997;21:325–9.
   Google Scholar
• Poklis A, Still J, Slattum PW, Edinboro LF, Saady JJ, Costantino A. Urinary excretion of d-amphetamine following oral doses in humans : implications for urine drug testing. J Anal Toxicol 1998; 22: 481–6.
   Google Scholar
• Tognoni G, Morselli PL, Garattini S. Amphetamine concentrations in rat brain and human urine after fenproporex administra-tion. Eur J Pharmacol 1972; 20: 125–6.
   Google Scholar
• Cody JT, Valtier S. Detection of amphetamine following administration of fenproporex. J Anal Toxicol 1996; 20: 425–431.
   Google Scholar
• Musshof F. Illegal or legitimate use? Precursor compounds to amphetamine and methamphetamine. Drug Metabol Rev 2000; 32: 15–44.
   Google Scholar
• Peat MA, Peat JJ. Cannabinoids. In : Caplan YH, Ed. Abused drugs monograph series Cannabinoids. Abbott Laboratories, Diagnostics Division, Irving Tx, 1994: 1–2.
   Google Scholar
• Halldin MM. The metabolism of cannabinoids. In : Lindman A, Askestad M, Seidlev K, eds. Proceedings of the 5th Nordic Seminar on drugs of abuse testing : Cannabinoids. Dade Behring, Rødovre 1998.
   Google Scholar
• Wennig R. Practical compendium for health professionals : Drugs of abuse currently used in Europe. Commission of the European communities CEC/V/E/l/LUX/61/92, Luxembourg 1992.
   Google Scholar
• Huestis HA. Recent advances in human kinetics and disposition of marijuana. Presentation given at the Premier Congrès de Toxicologie Hospitalière, Liège, October 1998.
   Google Scholar
• Smith-Kielland A. Pharmacology and pharmacokinetics of cannabinoids. In : Lindman A, Askestad M, Seidlev K, eds. Proceedings of the 5th Nordic Seminar on drugs of abuse testing : Cannabinoids. Dade Behring R0dovre 1998.
   Google Scholar
• Huestis HA, Mitchell JM, Cone EJ. Detection times of marijuana metabolites in urine by immunoassay and GC-MS. J Anal Toxicol 1995; 19: 443–9.
   Google Scholar
• Smith DE, Gutgesell ME, Schwartz RH, Thome MM, Bogema S. Federal guidelines for marijuana screening should have lower cut-off levels : a comparison of results from immunoassays and gas chromatography-mass spectrometry. Arch Pathol Lab Med 1989; 13(11): 1299–300.
   Google Scholar
• Smith-Kielland A, Skuterud B, Mϕrland JG. Urinary excretion of ll-nor-9-carboxy-D9THC (THCCOOH) and cannabinoids in drug users. J Anal Toxicol 1999; 23: 323–32.
   Google Scholar
• Huestis HA, Mitchell JM, Cone EJ. Urinary excretion profiles of ll-nor-9-carboxy-delta9-tetrahydrocannabinol in humans after single smoked doses of marijuana. J Anal Toxicol 1996; 20: 441–52.
   Google Scholar
• Wingert E. Lowering cut-offs for initial and confirmation testing for cocaine and marijuana : large-scale study of effects on the rates of drug-positive results. Clin Chem 1997; 43: 100–3.
   Google Scholar
• Cone EJ, Johnson RE, Paul BD, Mell LD, Mitchell J. Marijuana-laced brownies : Behavioral effects, physiologic effects, and uri-nalysis in humans following ingestion. J Anal Toxicol 1988; 12:169–75.
   Google Scholar
• Lafolie P, Beck O, Bleenow G, Boréus L, Borg S, Elwin CE, Karlsson L, Odelius G, Hjemdahl P. Importance of creatinine analyses of urine when screening for abused drugs. Clin Chem 1991; 37: 1927–31.
   Google Scholar
• Cone EJ, Johnson RE, Darwin WD, Yousefnejad D, Mell LD, Paul BD, Mitchell J. Passive inhalation of marijuana smoke : Urinalysis and room air levels of delta-9-tetrahydrocannabinol. J Anal Toxicol 1987 ;11: 89–96.
   Google Scholar
• Mule SJ, Lomax P, Gross SJ. Active and realistic passive marijuana exposure tested by three immunoassays and GC/MS in urine. J Anal Toxicol 1988 ; 12:113–6.
   Google Scholar
• Verebey K, Gold MS. From coca leaves to crack : the effects of dose and routes of administration in abuse liability. Psychiatr Ann 1988; 18:513–20.
   Google Scholar
• Ragoucy-Sengler C. Cocaïne. In : Kintz P. Toxicologie et pharmacologie médicolégales. Paris : Elsevier. 1998: 431–63.
   Google Scholar
• Baselt RC. Cocaine. In : Baselt RC. Disposition of toxic drugs and chemicals in man. Foster City, California : Chemical Toxicology Institute. 2000: 205–10.
   Google Scholar
• Hombeck C; Barton K; Czamy R. Urine Concentrations of ecgonine from specimens with low benzoylecgonine levels using a new ecgonine assay. J Anal Toxicol 1995; 19: 133–8.
   Google Scholar
• Cone E, Yousefnejad D, Darwin WD. Passive inhalation of co-caine. J Anal Toxicol 1995; 19: 399–411.
   Google Scholar
• Le SD, Ting E. Occupational exposure to cocaine involving crime lab personnel. J Forensic Sci 1991; 4: 959–68.
   Google Scholar
• Cone E, Menchen S, Mitchell J. Validity testing of commercial urine cocaine metabolite assays : I. Assay detection times, indi-vidual excretion patterns, and kinetics after cocaine administra-tion to humans. JFSCA 1989; 34: 15–31.
   Google Scholar
• Cone E, Menchen S, Mitchell J. Validity testing of TDx cocaine metabolite assay with human specimens obtained after intrave-nous cocaine administration. For Sci Int 1988; 37: 265–75.
   Google Scholar
• Baselt R, Chang R. Urinary excretion of cocaine and benzoylecgonine following oral ingestion in a single subject. J Anal Toxicol 1987; 11: 81–2.
   Google Scholar
• Hamilton H, Wallace J, Christenson J. Cocaine and benzoylecgonine excretion in humans. JFSCA 1977; 22: 697–707.
   Google Scholar
• Jufer R, Cone E, Walsh S. Urinary detection times following chronic oral cocaine administration to humans. Presented at the 1998 joint SOFT/TIAFT international meeting in Albuquerque, NM.
   Google Scholar
• Cone E, Weddington W. Prolonged occurrence of cocaine in human saliva and urine after chronic use. J Anal Toxicol 1989; 13:65–8.
   Google Scholar
• Burke W, Ravi N, Maany I. Prolonged presence of metabolite in urine after compulsive cocaine use. J Clin Psychiatr 1990; 51: 145–8.
   Google Scholar
• Weiss R, Gawin F. Protracted elimination of cocaine metabolites in long-term, high-dose cocaine abusers. American J Med 1988; 85: 879–80.
   Google Scholar
• Patrinely J, Cruz O, Reyna G, King J. The use of cocaine as an anesthetic in lacrimal surgery. J Anal Toxicol 1994; 18: 54–56.
   Google Scholar
• Pépin G. Opiacés et Opioïdes. In : Kintz P. Toxicologie et pharmacologie médicolégales. Paris : Elsevier. 1998: 335–430.
   Google Scholar
• Cone E, Jufer R, Darwin W. Forensic drug testing for opiates. VII. Urinary excretion profile of intranasal (snorted) heroin. J Anal Toxicol 1996; 20: 379–92.
   Google Scholar
• Baselt RC. Heroin. In : Baselt RC, ed. Disposition of toxic drugs and chemicals in man. Foster City, California : Chemical Toxicology Institute. 2000: 407–12.
   Google Scholar
• Goldberger BA. Opiates. In : Caplan YH, Ed. Abused drugs monograph series. Abbott Laboratories, Diagnostics Division, Irving Tx, 1994.
   Google Scholar
• Yngen M, Brodin K. Distinguishing codeine, heroin and ethyl- morphine intake. In : Lindman A, Askestad M. The third Nordic seminar on drugs of abuse testing : opiates and methadone. Behring Diagnostics Skàrholmen, 1996.
   Google Scholar
• Chang B, Huang M. Urinary excretion of codeine and morphine following the administration of codeine containing cold syrup. J Anal Toxicol 2000; 24: 133–9.
   Google Scholar
• Guldberg H, Aamo T. Consequences of new screening cut-offs for opiates. In : Lindman A, Askestad M. The third Nordic seminar on drugs of abuse testing : opiates and methadone. Behring Diagnostics Skàrholmen, 1996.
   Google Scholar
• Cone E, Welch P, Mitchell J, Paul B. Forensic drug testing for opiates : I. Detection of 6-acetylmorphine in urine as an indica-tor of recent heroin exposure; drug and assay considerations and detection times. J Anal Toxicol 1991; 15: 1–7.
   Google Scholar
• Cone E, Jenkins A, Paul BD. Detection times of morphine and . 6-acetylmorphine in urine after intravenous heroin. Presented at the 1998 joint SOFT/TIAFT international meeting in Albuquerque, NM
   Google Scholar
• Smith M, Paul BD, Cone E. Detection times of 6-acetylmorphine, free morphine and total morphine in urine after smoking heroin. Presented at the 1998 joint SOFT/TIAFT international meeting in Albuquerque, NM
   Google Scholar
• Kadehijan L. Clinical and regulatory issues in urine drug testing for opiates. In : Lindman A, Askestad M. The third Nordic seminar on drugs of abuse testing : opiates and methadone. Behring Diagnostics Skarholmen, 1996
   Google Scholar